DIG
ACIU icon

Dauntless Investment Group’s AC Immune ACIU Stock Holding History

Dauntless Investment Group’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-107,489
Closed -$296K – 74
2026
Q1 		$296K Sell
107,489
-8,188
-7% -$25.4K 0.2% 41
2025
Q4 		$363K Buy
+115,677
New +$365K 0.29% 40

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dauntless Investment Group's ACIU Position: Q2 2026 in Review

Dauntless Investment Group sold out of AC Immune (ACIU) in Q2 2026, closing a stake of 107,489 shares — an estimated $296K sold.

Dauntless Investment Group first reported a position in ACIU in Q4 2025 and held it in 2 quarters. The position peaked at $363K in Q4 2025. 43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • Dauntless Investment Group reported no remaining AC Immune position as of Q2 2026 after selling out during the quarter.
  • Dauntless Investment Group sold 107,489 AC Immune shares in Q2 2026, an estimated $296K.
  • Dauntless Investment Group first reported a position in AC Immune in Q4 2025 and held it in 2 quarters.
  • Dauntless Investment Group's AC Immune position peaked at $363K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on Dauntless Investment Group's 13F filing for Q2 2026, filed 13 Aug 2026.